Clinical trials
Withdrawn Hematologic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 3 |
| 2009 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Cincinnati | 2 |
| Accriva Diagnostics | 1 |
| Baptist Health South Florida | 1 |
| Bellicum Pharmaceuticals | 1 |
| Canadian Myeloma Research Group | 1 |
| Cangene Corporation | 1 |
| Case Comprehensive Cancer Center | 1 |
| Celgene | 1 |
| Enzon Pharmaceuticals, Inc. | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 21 |
| Neoplasms | 5 |
| Multiple Myeloma | 4 |
| Blood Coagulation Disorders | 3 |
| Hematologic Neoplasms | 3 |
| Hemorrhagic Disorders | 3 |
| Myelodysplastic Syndromes | 3 |
| Immune System Diseases | 2 |
| Leukemia | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
Trials
Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.